Rankings
▼
Calendar
ELUT (Elutia Inc.) Stock Financials & Earnings | Market Cap Arena
ELUT
Elutia Inc.
Mkt Cap
$48M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$21M
Net Income (TTM)
-$26M
EPS (TTM)
-$0.92
Free Cash Flow (TTM)
-$33M
Gross Margin
46.0%
Op. Margin
-149.1%
Net Margin
-125.6%
FCF Margin
-158.3%
P/S Ratio (TTM)
2.3x
P/E Ratio (TTM)
—
YoY Rev Growth
-14.9%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Next: Q4 2025 · Mar 11
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$13M
$5M
-$9M
Q1 23
$6M
$3M
-$8M
Q2 23
$6M
$3M
-$6M
Q3 23
$6M
$3M
-$7M
Q4 23
$6M
$2M
-$9M
Q1 24
$7M
$3M
-$8M
Q2 24
$6M
$3M
-$9M
Q3 24
$6M
$3M
-$10M
Q4 24
$5M
$2M
-$8M
Q1 25
$6M
$2M
-$8M
Q2 25
$6M
$3M
-$10M
Q3 25
$3M
$2M
-$5M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
1.1x
—
Q1 23
1.3x
—
Q2 23
1.6x
—
Q3 23
1.5x
—
Q4 23
2.0x
—
Q1 24
1.9x
—
Q2 24
1.9x
—
Q3 24
2.0x
—
Q4 24
2.0x
—
Q1 25
2.0x
—
Q2 25
2.0x
—
Q3 25
2.3x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$5M
-$5M
Q1 23
-$5M
-$5M
Q2 23
-$2M
-$2M
Q3 23
-$5M
-$5M
Q4 23
-$10M
-$10M
Q1 24
-$3M
-$3M
Q2 24
-$4M
-$4M
Q3 24
-$3M
-$4M
Q4 24
-$12M
-$12M
Q1 25
-$9M
-$9M
Q2 25
-$8M
-$8M
Q3 25
-$3M
-$4M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$134K
Q1 23
$182K
Q2 23
$85K
Q3 23
$62K
Q4 23
$17K
Q1 24
$15K
Q2 24
$2K
Q3 24
$547K
Q4 24
$94K
Q1 25
$278K
Q2 25
$114K
Q3 25
$630K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
+16.6%
+15.5%
Q1 23
-44.4%
-20.0%
Q2 23
-49.7%
-39.2%
Q3 23
+4.8%
-8.9%
Q4 23
-53.6%
-33.1%
Q1 24
+4.7%
+3.0%
Q2 24
-0.9%
+16.9%
Q3 24
-3.3%
+19.7%
Q4 24
-6.9%
-3.4%
Q1 25
-9.9%
-8.0%
Q2 25
-0.4%
+9.0%
Q3 25
-43.9%
-47.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$774K
6.1%
Q1 23
$684K
10.7%
Q2 23
$687K
10.8%
Q3 23
$0
0.0%
Q4 23
$0
0.0%
Q1 24
$2M
32.8%
Q2 24
$0
0.0%
Q3 24
$0
0.0%
Q4 24
$1M
22.1%
Q1 25
$1M
20.1%
Q2 25
$1M
18.3%
Q3 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q4 22
$2M
$3M
$5M
Q1 23
$2M
$4M
$5M
Q2 23
$869K
$4M
$3M
Q3 23
$557K
$3M
$3M
Q4 23
$1M
$4M
$3M
Q1 24
$1M
$5M
$3M
Q2 24
$1M
$5M
$3M
Q3 24
$778K
$5M
$3M
Q4 24
$834K
$4M
$3M
Q1 25
$905K
$4M
$3M
Q2 25
$1M
$4M
$4M
Q3 25
$1M
$4M
$2M
marketcaparena.com
Revenue Segments
Cardiovascular
Women's Health
Quarter
Cardiovascular
Women's Health
Q3 25
$944K
$2M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$17M
$0
$17M
Q1 23
$12M
$0
$12M
Q2 23
$9M
$0
$9M
Q3 23
$15M
$0
$15M
Q4 23
$19M
$0
$19M
Q1 24
$13M
$0
$13M
Q2 24
$18M
$0
$18M
Q3 24
$26M
$0
$26M
Q4 24
$13M
$0
$13M
Q1 25
$17M
$0
$17M
Q2 25
$9M
$0
$9M
Q3 25
$5M
$0
$5M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
14M
+5.9%
Q1 23
16M
+11.6%
Q2 23
16M
+0.5%
Q3 23
17M
+4.9%
Q4 23
23M
+36.3%
Q1 24
24M
+3.1%
Q2 24
25M
+4.1%
Q3 24
36M
+42.7%
Q4 24
35M
-1.9%
Q1 25
43M
+23.2%
Q2 25
46M
+7.9%
Q3 25
45M
-1.8%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
$458K
54
FY 24
$478K
51
marketcaparena.com
